title: Pramipexole, ropinirole, and mania in Parkinson's disease.
authors.forename: Abhay
authors.initials: A
authors.lastname: Singh
authors.forename: Robert
authors.initials: R
authors.lastname: Althoff
authors.forename: R Jared
authors.initials: RJ
authors.lastname: Martineau
authors.forename: James
authors.initials: J
authors.lastname: Jacobson
mesh_terms: D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D052160:Benzothiazoles; D001714:Bipolar Disorder / Q000139:chemically induced*; D018491:Dopamine Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D000077487:Pramipexole; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000978:Antiparkinson Agents; D052160:Benzothiazoles; D018491:Dopamine Agonists; D007211:Indoles; D013844:Thiazoles; C046649:ropinirole; D007980:Levodopa; D000077487:Pramipexole